PITTSBURGH--(BUSINESS WIRE)--Abridge, the leader in generative AI for clinical documentation, announced an additional $150 million investment, leveraging momentum from their product’s rapid uptake among health systems throughout the nation. This raise comes just 4 months after their $30M Series B, and is one of the largest funding rounds made to date in generative AI for healthcare..

匹兹堡--（商业新闻短讯）--Abridge，临床文档生成人工智能的领导者，宣布额外投资1.5亿美元，利用其产品在全国卫生系统中迅速普及的势头。此次加薪是在他们3000万美元的B系列融资4个月后进行的，也是迄今为止针对医疗保健的生成性人工智能最大的融资回合之一。。

The Series C investment was led by Lightspeed Venture Partners, who will also join the board. Other new and existing investors continuing to support the company include co-lead Redpoint Ventures, with support from IVP, Spark Capital, Union Square Ventures, Bessemer Venture Partners, Wittington Ventures, Mass General Brigham Artificial Intelligence and Digital Innovation Fund (AIDIF), Kaiser Permanente Ventures, and CVS Health Ventures..

C系列投资由Lightspeed Venture Partners牵头，他们也将加入董事会。其他继续支持该公司的新投资者和现有投资者包括联合牵头的Redpoint Ventures，并得到了IVP、Spark Capital、Union Square Ventures、Bessemer Venture Partners、Wittington Ventures、Mass General Brigham Artificial Intelligence and Digital Innovation Fund（AIDIF）、Kaiser Permanente Ventures和CVS Health Ventures的支持。。

Today, Abridge also announced a new enterprise agreement with the Yale New Haven Health System, the largest and most comprehensive healthcare system in Connecticut, that will give thousands of clinicians access to Abridge for clinical documentation. Yale New Haven Health has selected Abridge as their generative AI partner in this area of ambient listening.

今天，Abridge还宣布与康涅狄格州最大和最全面的医疗保健系统耶鲁纽黑文健康系统达成新的企业协议，这将使数千名临床医生能够获得Abridge的临床文件。耶鲁纽黑文健康学院选择Abridge作为他们在环境倾听领域的生成人工智能合作伙伴。

The initial deployment will be focused on reducing the cognitive burden of clinical documentation, enabling clinicians to spend more face-to-face time engaging with patients instead of computers..

最初的部署将侧重于减轻临床文档的认知负担，使临床医生能够花更多的时间与患者面对面交流，而不是使用计算机。。

“Freeing doctors from the burden of documentation will dramatically improve both quality of care and the doctor-patient relationship,” said Paul Ricci, Advisor, Lightspeed Venture Partners, and former Chairman and CEO of Nuance Communications. “Abridge will allow caregivers to capture an enormous amount of data that is currently being discarded or ignored, and that in turn will likely lead to new insights in managing population health.

Lightspeed Venture Partners顾问、Nuance Communications前董事长兼首席执行官保罗·里奇（PaulRicci）表示：“让医生摆脱文件负担，将大大改善护理质量和医患关系。”。“简略将使护理人员能够捕获目前被丢弃或忽略的大量数据，这反过来可能会为管理人口健康带来新的见解。

I’m thrilled to work with Dr. Rao and his team on the next great step in the evolution of healthcare.”.

我很高兴能与Rao博士及其团队合作，推动医疗保健发展的下一个伟大步骤。”。

“Abridge has set new standards for quality and responsible deployment of generative AI in health systems across the U.S., cementing it as the industry’s most trusted AI platform,” said Sebastian Duesterhoeft, Partner at Lightspeed Venture Partners. “Abridge stands out for their innovation in all facets of product development.

Lightspeed Venture Partners合伙人塞巴斯蒂安·杜斯特霍夫特（SebastianDuesterhoeft）表示：“Abridge为美国卫生系统中生成型人工智能的质量和负责任部署制定了新标准，巩固了它作为业界最值得信赖的人工智能平台的地位。”。“Abridge在产品开发的各个方面都有创新。

CTO Zack Lipton, a widely cited Associate Professor at Carnegie Mellon and pioneer in responsible AI research, has assembled the strongest research team in healthcare AI. They have set new expectations for transparency and verification with their evidence extraction technology, and raised the bar for both note quality and evaluation methodology.”.

卡内基梅隆大学（CarnegieMellon）被广泛引用的副教授、负责任人工智能研究的先驱扎克·利普顿（CTO Zack Lipton）组建了医疗保健人工智能领域最强大的研究团队。他们对证据提取技术的透明度和验证提出了新的期望，并提高了笔记质量和评估方法的门槛。”。

Abridge has been assembling a world-class AI team for years and these investments are rapidly hitting production. In the last year alone, they delivered an industry-leading automatic speech recognition engine purpose-built for healthcare applications. Their speech and language technologies have been rigorously evaluated in 14 languages and functionally support many more—performing well even amidst rapid switches between languages and when interpreters are in the room.

多年来，Abridge一直在组建一支世界级的人工智能团队，这些投资正在迅速影响生产。仅在去年，他们就推出了一款行业领先的自动语音识别引擎，专门为医疗保健应用而设计。他们的语音和语言技术已经用14种语言进行了严格的评估，即使在语言之间快速切换以及口译员在场的情况下，功能上也支持更多的表现良好的人。

Abridge is ahead of the market in controlling its full technology pipeline, developing its own purpose-built LLMs. Moreover, its “Linked Evidence” feature, a first-of-its kind technology that maps any highlighted region within a summary to the substantiating evidence in the source transcript (and thus to the underlying audio) has become a required capability.

Abridge在控制其全部技术管道、开发自己的专用LLM方面领先于市场。此外，它的“关联证据”功能是第一种将摘要中的任何突出显示区域映射到源笔录中的确凿证据（从而映射到底层音频）的同类技术，已成为必需的功能。

The company is actively developing novel ways to personalize notes, integrate more deeply into the EMR, and provide clinicians with after-visit insights..

该公司正在积极开发新颖的方法来个性化笔记，更深入地融入电子病历，并为临床医生提供访问后的见解。。

With this new capital, Abridge will continue to push boldly into fundamental research, developing bedrock foundation models that draw upon vast troves of multimodal healthcare data. These models will both power improvements to Abridge’s existing product lines and enable a new wave of possibilities in the future..

有了这笔新资金，Abridge将继续大胆推进基础研究，开发利用大量多模式医疗保健数据的基础模型。这些模型既可以改进现有的产品线，又可以在未来带来新一波的可能性。。

“We are grateful to be partnering with iconic institutions that share our dedication to improving the lives of patients and clinicians,” said Dr. Shiv Rao, CEO and Founder of Abridge. “This company was founded on the premise that clinician-patient conversations are at the core of all healthcare. Already, this information is powering a revolution in AI-based documentation.

Abridge首席执行官兼创始人Shiv Rao博士表示：“我们很高兴与标志性机构合作，分享我们对改善患者和临床医生生活的贡献。”。“这家公司成立的前提是，临床医生与患者的对话是所有医疗保健的核心。这些信息已经推动了基于人工智能的文档的革命。

In the future, it will open new pathways to improve patient outcomes. Realizing this vision requires world-class talent and formidable compute resources. We are now uniquely positioned to build the AI platform that brings this vision to life.”.

在未来，它将开辟新的途径来改善患者的预后。实现这一愿景需要世界一流的人才和强大的计算资源。我们现在处于构建AI平台的独特位置，该平台将这一愿景带入生活。”。

About Abridge

关于Abridge

Abridge was founded in 2018 with the mission of powering deeper understanding in healthcare. The AI-powered platform was purpose-built for medical conversations, improving clinical documentation efficiencies while enabling clinicians to focus on what matters most—their patients.

Abridge成立于2018年，其使命是加深对医疗保健的理解。人工智能平台专门为医疗对话而构建，提高了临床文档的效率，同时使临床医生能够专注于最重要的患者。

Abridge’s enterprise-grade technology transforms patient-clinician conversations into structured clinical notes in real-time with deep EMR integrations. Powered by Linked Evidence and their auditable AI, Abridge is the only company that maps AI-generated summaries to ground truth, helping providers quickly trust and verify the output.

Abridge的企业级技术通过深度EMR集成将患者与临床医生的对话实时转换为结构化的临床笔记。凭借相关证据及其可审计的人工智能，Abridge是唯一一家将人工智能生成的摘要映射到基本事实的公司，帮助提供商快速信任和验证输出。

As pioneers in generative AI for healthcare, Abridge is setting the industry standards for the responsible deployment of AI across health systems..

作为医疗保健产生式人工智能的先驱，Abridge正在为跨医疗系统负责任地部署人工智能制定行业标准。。